Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia. Blood 2004 Mar 01;103(5):1969-71
Date
02/21/2004Pubmed ID
14976065DOI
10.1182/blood-2003-11-3951Scopus ID
2-s2.0-1442331659 (requires institutional sign-in at Scopus site) 44 CitationsAuthor List
Rosenblum MD, LaBelle JL, Chang CC, Margolis DA, Schauer DW, Vesole DHAuthor
David A. Margolis MD Chair, Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AlemtuzumabAntibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm
Antineoplastic Agents
Female
Flow Cytometry
Humans
Immunophenotyping
Leukemia, Lymphoid
Leukemia, T-Cell
Middle Aged
Treatment Outcome
